Cargando…
A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging
OBJECTIVE: Neuromelanin loss of substantia nigra (SN) can be visualized as a T1 signal reduction on T1-weighted high-resolution imaging. We investigated whether volumetric analysis of T1 hyperintensity for SN could be used to differentiate between Parkinson's disease dementia (PDD), Alzheimer...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007389/ https://www.ncbi.nlm.nih.gov/pubmed/27587951 http://dx.doi.org/10.3348/kjr.2016.17.5.633 |
_version_ | 1782451201653080064 |
---|---|
author | Moon, Won-Jin Park, Ju-Yeon Yun, Won-Sung Jeon, Ji Yeong Moon, Yeon Sil Kim, Heejin Kwak, Ki-Chang Lee, Jong-Min Han, Seol-Heui |
author_facet | Moon, Won-Jin Park, Ju-Yeon Yun, Won-Sung Jeon, Ji Yeong Moon, Yeon Sil Kim, Heejin Kwak, Ki-Chang Lee, Jong-Min Han, Seol-Heui |
author_sort | Moon, Won-Jin |
collection | PubMed |
description | OBJECTIVE: Neuromelanin loss of substantia nigra (SN) can be visualized as a T1 signal reduction on T1-weighted high-resolution imaging. We investigated whether volumetric analysis of T1 hyperintensity for SN could be used to differentiate between Parkinson's disease dementia (PDD), Alzheimer's disease (AD) and age-matched controls. MATERIALS AND METHODS: This retrospective study enrolled 10 patients with PDD, 18 patients with AD, and 13 age-matched healthy elderly controls. MR imaging was performed at 3 tesla. To measure the T1 hyperintense area of SN, we obtained an axial thin section high-resolution T1-weighted fast spin echo sequence. The volumes of interest for the T1 hyperintense SN were drawn onto heavily T1-weighted FSE sequences through midbrain level, using the MIPAV software. The measurement differences were tested using the Kruskal-Wallis test followed by a post hoc comparison. RESULTS: A comparison of the three groups showed significant differences in terms of volume of T1 hyperintensity (p < 0.001, Bonferroni corrected). The volume of T1 hyperintensity was significantly lower in PDD than in AD and normal controls (p < 0.005, Bonferroni corrected). However, the volume of T1 hyperintensity was not different between AD and normal controls (p = 0.136, Bonferroni corrected). CONCLUSION: The volumetric measurement of the T1 hyperintensity of SN can be an imaging marker for evaluating neuromelanin loss in neurodegenerative diseases and a differential in PDD and AD cases. |
format | Online Article Text |
id | pubmed-5007389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | The Korean Society of Radiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-50073892016-09-01 A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging Moon, Won-Jin Park, Ju-Yeon Yun, Won-Sung Jeon, Ji Yeong Moon, Yeon Sil Kim, Heejin Kwak, Ki-Chang Lee, Jong-Min Han, Seol-Heui Korean J Radiol Neuroimaging and Head & Neck OBJECTIVE: Neuromelanin loss of substantia nigra (SN) can be visualized as a T1 signal reduction on T1-weighted high-resolution imaging. We investigated whether volumetric analysis of T1 hyperintensity for SN could be used to differentiate between Parkinson's disease dementia (PDD), Alzheimer's disease (AD) and age-matched controls. MATERIALS AND METHODS: This retrospective study enrolled 10 patients with PDD, 18 patients with AD, and 13 age-matched healthy elderly controls. MR imaging was performed at 3 tesla. To measure the T1 hyperintense area of SN, we obtained an axial thin section high-resolution T1-weighted fast spin echo sequence. The volumes of interest for the T1 hyperintense SN were drawn onto heavily T1-weighted FSE sequences through midbrain level, using the MIPAV software. The measurement differences were tested using the Kruskal-Wallis test followed by a post hoc comparison. RESULTS: A comparison of the three groups showed significant differences in terms of volume of T1 hyperintensity (p < 0.001, Bonferroni corrected). The volume of T1 hyperintensity was significantly lower in PDD than in AD and normal controls (p < 0.005, Bonferroni corrected). However, the volume of T1 hyperintensity was not different between AD and normal controls (p = 0.136, Bonferroni corrected). CONCLUSION: The volumetric measurement of the T1 hyperintensity of SN can be an imaging marker for evaluating neuromelanin loss in neurodegenerative diseases and a differential in PDD and AD cases. The Korean Society of Radiology 2016 2016-08-23 /pmc/articles/PMC5007389/ /pubmed/27587951 http://dx.doi.org/10.3348/kjr.2016.17.5.633 Text en Copyright © 2016 The Korean Society of Radiology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Neuroimaging and Head & Neck Moon, Won-Jin Park, Ju-Yeon Yun, Won-Sung Jeon, Ji Yeong Moon, Yeon Sil Kim, Heejin Kwak, Ki-Chang Lee, Jong-Min Han, Seol-Heui A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging |
title | A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging |
title_full | A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging |
title_fullStr | A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging |
title_full_unstemmed | A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging |
title_short | A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging |
title_sort | comparison of substantia nigra t1 hyperintensity in parkinson's disease dementia, alzheimer's disease and age-matched controls: volumetric analysis of neuromelanin imaging |
topic | Neuroimaging and Head & Neck |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007389/ https://www.ncbi.nlm.nih.gov/pubmed/27587951 http://dx.doi.org/10.3348/kjr.2016.17.5.633 |
work_keys_str_mv | AT moonwonjin acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT parkjuyeon acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT yunwonsung acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT jeonjiyeong acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT moonyeonsil acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT kimheejin acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT kwakkichang acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT leejongmin acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT hanseolheui acomparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT moonwonjin comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT parkjuyeon comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT yunwonsung comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT jeonjiyeong comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT moonyeonsil comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT kimheejin comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT kwakkichang comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT leejongmin comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging AT hanseolheui comparisonofsubstantianigrat1hyperintensityinparkinsonsdiseasedementiaalzheimersdiseaseandagematchedcontrolsvolumetricanalysisofneuromelaninimaging |